Effect of secukinumab on the different GRAPPA-OMERACT core domains in psoriatic arthritis: a pooled analysis of 2049 patients by Orbai, A-M, McInnes, IB, Coates, LC, Husni, ME, Gladman, DD, Gossec, L, Pricop, L, Chambenoit, O, Meng, X, Mease, PJ

Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR) by Orbai, A-M, Ogdie, A, Gossec, L, Tillett, W, Leung, YY, Gao, J, Trivedi, M, Tasset, C, Meuleners, L, Besuyen, R, Hendrikx, T, Coates, LC

Association between patient perception of disease status and different components of the Minimal Disease Activity (MDA) criteria in psoriatic arthritis by Yazji, SM, Helliwell, PS, Balanescu, A, Dernis, E, Kiltz, U, Kalyoncu, U, Leung, YY, Orbai, A-M, Smolen, JS, de Wit, M, Gossec, L, Coates, LC

Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire by Coates, LC, Orbai, A-M, Azevedo, VF, Cappelleri, JC, Steinberg, K, Lippe, R, Lim, I, Eder, L, Richette, P, Weng, MY, Queiro Silva, R, Fallon, L

Meaningful improvement in general health outcomes with Guselkumab treatment for psoriatic arthritis: Patient-Reported Outcomes Measurement Information System-29 results from a phas... by Orbai, A-M, Coates, LC, Deodhar, A, Helliwell, PS, Ritchlin, CT, Leibowitz, E, Kollmeier, AP, Hsia, EC, Xu, XL, Sheng, S, Jiang, Y, Liu, Y, Han, C

Appraisal of candidate instruments for assessment of the physical function domain in patients with psoriatic arthritis by Leung, YY, Orbai, A-M, Ogdie, A, Hojgaard, P, Holland, R, Goel, N, Chau, J, Coates, LC, Strand, V, Gladman, DD, Mease, P, Christensen, R, Tillett, W

Test-retest reliability for HAQ-DI and SF-36 PF for the measurement of physical function in psoriatic arthritis by Leung, YY, Tillett, W, Hojgaard, P, Orbai, A-M, Holland, R, Mathew, AJ, Goel, N, Chau, J, Lindsay, C, Ogdie, A, Coates, LC, Christensen, R, Mease, P, Strand, V, Gladman, DD

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review by Leung, Y-Y, Holland, R, Mathew, AJ, Lindsay, C, Goel, N, Ogdie, A, Orbai, A-M, Hojgaard, P, Chau, J, Coates, LC, Strand, V, Gladman, DD, Christensen, R, Tillett, W, Mease, P

OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF by Leung, Y-Y, Orbai, A-M, Hojgaard, P, Holland, R, Mathew, AJ, Goel, N, Chau, J, Tillett, W, Lindsay, C, Ogdie, A, Coates, LC, Gladman, DD, Christensen, R, Mease, P, Strand, V

Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cro... by Leung, Y-Y, Eder, L, Orbai, A-M, Coates, LC, de Wit, M, Smolen, JS, Kiltz, U, Palominos, P, Cañete, JD, Scrivo, R, Balanescu, A, Dernis, E, Meisalu, S, Soubrier, M, Kalyoncu, U, Gossec, L

Initiating evaluation of composite outcome measures for psoriatic arthritis: 2022 updates from the GRAPPA-OMERACT Working Group by Leung, Y-Y, Tillett, W, de Wit, M, Orbai, A-M, Coates, LC, FitzGerald, O, Helliwell, PS, Strand, V, Mease, P, Goel, N, Christensen, R, Merola, JF, Lindsay, C, Ogdie, A, Gossec, L, Gladman, DD

Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiative by Antony, A, Holland, R, D'Agostino, M-A, Maksymowych, WP, Bertheussen, H, Schick, L, Goel, N, Ogdie, A, Orbai, A-M, Højgaard, P, Coates, LC, Strand, V, Gladman, DD, Christensen, R, Leung, YY, Mease, P, Tillett, W

Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III... by Coates, LC, Landewé, R, McInnes, IB, Mease, PJ, Ritchlin, CT, Tanaka, Y, Asahina, A, Behrens, F, Gladman, DD, Gosse, L, Orbai, A-M, Gottlieb, AB, Warren, RB, Ink, B, Bajracharya, R, Shende, V, Coarse, J, Merola, JF

Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries by Sousa, M, Lubrano, E, Smolen, JS, Gorlier, C, de Wit, M, Coates, LC, Kalyoncu, U, Ruyssen-Witrand, A, Leung, Y-Y, Scrivo, R, Cañete, JD, Palominos, P, Meisalu, S, Balanescu, A, Kiltz, U, Zehra Aydin, S, Gaydukova, I, Dernis, E, Fautrel, B, Orbai, A-M, Gossec, L

Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries by Lucasson, F, Kiltz, U, Kalyoncu, U, Leung, Y-Y, Palominos, P, Cañete, JD, Scrivo, R, Balanescu, A, Dernis, E, Meisalu, S, Ruyssen-Witrand, A, Soubrier, M, Zehra Aydin, S, Eder, L, Gaydukova, I, Lubrano, E, Richette, P, Husni, ME, Coates, LC, de Wit, M, Smolen, JS, Orbai, A-M, Gossec, L